1,2,3Fayemiwo, S. A., and *4Adegboro, B.
1Department of Medical Microbiology and Parasitology, University College Hospital, Ibadan, Nigeria
2Medical Mycology Unit, Infectious Diseases Institute, College of Medicine, University of Ibadan, Nigeria
3Division of Infection, Immunity and Respiratory Medicine, Faculty of Biology, Medicine and Health, School of Biological Sciences, University of Manchester, Manchester, United Kingdom
4Department of Medical Microbiology and Immunology, Nile University of Nigeria, Abuja, Nigeria *Correspondence to: boazadegboro@gmail.com and boaz.adegboro@nileuniversity.edu.ng
Abstract:
Invasive fungal diseases (IFDs) are major causes of morbidity and mortality among hospitalized patients all over the world with a global prevalence of 15%. Since the first case of COVID-19 was reported on February 27, 2020, in Nigeria, it had been discovered across all geopolitical zones in Nigeria. As the medical community confronts the ongoing COVID-19 pandemic, determining whether patients infected with SARS-CoV-2 develop fungal complications, especially invasive aspergillosis, is crucial. This review aimed to highlight the fungal co-infections that might be associated with SARS-CoV-2 infection, and modalities for their diagnosis, prevention, and management, with the view to reducing the high mortality associated with these infections. Continue reading “Invasive fungal infections and COVID-19: a review”